We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Epidermal Growth Factor Receptor Stimulates Early Cancer Metastasis

By LabMedica International staff writers
Posted on 15 Nov 2015
Print article
Image: Diagram of the epidermal growth factor receptor (EGFR) (rainbow colored, N-terminus = blue, C-terminus = red) complexed to its ligand epidermal growth factor (magenta) (Photo courtesy of Wikimedia Commons).
Image: Diagram of the epidermal growth factor receptor (EGFR) (rainbow colored, N-terminus = blue, C-terminus = red) complexed to its ligand epidermal growth factor (magenta) (Photo courtesy of Wikimedia Commons).
The stimulation of blood vessel formation by epidermal growth factor receptor (EGFR) early in tumor development was found to facilitate metastasis of the original tumor even before it was diagnosed.

Mutations that lead to EGFR overexpression have been associated with a number of cancers, including lung cancer, anal cancers, and the brain cancer glioblastoma multiforme. Somatic mutations involving EGFR lead to its constant activation, which produces uncontrolled cell division.

Many malignant characteristics of cancer cells are regulated through pathways induced by the tyrosine kinase activity of EGFR. Investigators at the Scripps Research Institute (La Jolla, CA, USA) reported in a study that was published in the August 2015 issue of the journal Neoplasia that besides directly affecting the biology of cancer cells, EGFR also regulated the primary tumor microenvironment. Specifically, their findings demonstrated that both the expression and signaling activity of EGFR were required for the induction of a distinct intratumoral vasculature capable of sustaining tumor cell intravasation, an early step of metastatic dissemination during which tumor cells enter angiogenic blood vessels, which is a critical rate-limiting step in the metastatic cascade.

The investigators stated that this study unraveled an important but overlooked function of EGFR in cancer, namely, its ability to create an intravasation-sustaining microenvironment within the developing primary tumor by orchestrating several interrelated processes required for the initial steps of cancer metastasis through vascular routes. Their findings also suggested that EGFR-targeted therapies might be more effective when implemented in cancer patients with early-staged primary tumors containing a VEGF (vascular endothelial growth factor)-dependent angiogenic vasculature.

In experiments using chick embryos, the investigators found that EGFR signaling triggered a chain reaction inside tumor cells, ultimately resulting in the release of VEGF, known to be active in almost all forms of solid tumors. Released VEGF then bound to endothelial cells, inducing the growth of new blood capillaries and vessels within a developing tumor.

"When cancer cells have high levels of EGFR, the tumor has a lot of new, angiogenic blood vessels," said senior author Dr. Elena Deryugina assistant professor of cell and molecular biology at the Scripps Research Institute. "And these vessels are very welcoming for tumor cells and facilitate their dissemination from the very early stages of tumor development. Now we have learned that these newly formed vessels are used by tumor cells for dissemination because of their certain structural properties."

Related Links:
Scripps Research Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.